pacDNA’s mission is to greatly expand the disease areas where an oligonucleotide-based therapy can be developed. Our proprietary delivery technology, termed the Brushield™, boosts the biodistribution in otherwise hard-to-deliver sites, reduces potential side effects, and generates lasting potency, which makes it possible to develop multiple therapies for diseases that are currently out of reach.